Share Market Archives - Stocksbaazigar
Stocksbaazigar - The Ultimate Wealth Creator

Bikaji Foods acquires Hanuman Agrofood

The recently listed company Bikaji Foods International Ltd is making news for good reasons. Stock was 4% up on the Wednesday after strong second quarter performance and acquisition of Hanuman Agrofoods. The ethnic snacks player Bikaji Foods got listed with 8% on 322.80 in the month of November. Since then it has given more than 30% returns to shareholders who continued to hold the shares from IPOs. Bikaji Foods made high of 415.35 on 7th December 2022 after the stellar Q2 performance. Market cap of Bikaji reached Rs 10290 Crores after this price movement. Net Profit grew by 43.2%, Revenue grew by 32%, EBITDA margin came 11.4% thanks to softening of raw materials prices. Many categories showed double digit growth. Valuations wise Bikaji Foods International Ltd shares are now very expensive as compared to other FMCG players. In the separate filing with the exchanges, company announced that it will exercise the ‘right of conversion’ of preferential shares of Hanuman Agrofoods into equity shares. Under this 28,13,050 compulsory convertible cumulative preference shares will be converted into equity shares making Hanuman Agrofood Pvt Ltd. a Subsidiary of Bikaji International Foods Ltd. Bikaji Foods shares have given tremendous returns to investors and it is very expensive share now. New entry is not recommended at these levels. Due to upcoming Christmas and New year season we may see good demand in Snacks business. Company will continue to perform good in the coming quarters. We can wait for the sizeable correction in the stock to make fresh entry. Those who have shares of Bikaji can book partial profit and hold the remaining shares. Disclaimer: Stocksbaazigar Mr. Deepak Doddamani is not a SEBI registered advisor. He is NSE’s Certified Investment Analysis Professional, NSE’s Certified Marketing Professional Level – 4, AMFI registered Mutal Funds distributor and Authorized Person with IIFL Securities Ltd. This post is for educational purpose and Stocksbaazigar is not responsible for any Profit/Loss of reader. Please consult your financial advisor before taking any investment decision.

J K Paper acquires HPPL and SPPL

Stock of JK Paper was 4% up on Tuesday morning and made high of 436. It closed near 415.20 after the profit-booking by traders. This intraday rally in stock was a response to the news that came on Monday evening about J K Paper’s acquisition of HPPL and SPPL. Here is the full story. On Monday, in the filing with SEBI, J K Paper said that it is acquiring Mumbai based Horizon Packs Pvt Ltd and Uttarakhand based Securipax Packaging Pvt Ltd. 85% acquisition will take place immediately and remaining 15% will take place over 3 years duration. J K Paper has entered in separate Share Purchase and Shareholder’s Agreements with both the companies. Accordingly it informed that the purchase consideration of for acquisition of 85% equity shares of HPPL will be Rs 19.33 per equity share of 10 Rs each and for acquisition of 85% equity shares of SPPL it will be Rs. 1256.95 per equity share of 100 Rs. each. J K Paper will acquire 26.92 Crore share of HPPL and 4.63 Lac shares of SPPL under the considerations mentioned above. E-Commerce based-delivery businesses brought golden days to Paper Industry. Corrugated Brown Boxes are widely used by many E-Commerce players for delivery of products to their customers. JK Paper already manufactures and supplies corrugated packaging papers to various industries. It’s upcoming Ludhiana facility will also focus more on manufacturing of packaging papers. With acquisition of HPPL and SPPL, J K Paper will now become the largest Corrugated Packaging Manufacturer in India. Horizon Packs Pvt Ltd has six manufacturing plants across India while Sucuripax Packaging has facility in Roorkee where Corrugated Packaging or Brown Boxes papers are manufactured. J.K Paper is spending Rs 578 Crores for these acquisitions to become leader in this segment. I have already done detailed Fundamental Analysis of J K Paper on this stock and recommended it for long term when it was consolidating between 130-160 range few years ago (Iin the year 2019). You can read it here. Now stock it above 400+ levels. It has already given 180% returns from its 52 week low. Hence, I feel that fresh entry in this stocks should be avoided. Stock is over-valued and need to be cooled down considering the dream run it has given. If you already have it, you can hold it by keeping your Stop Loss at 398. Disclaimer: Please note Stocksbaazigar Mr Deepak Doddamani is not a SEBI Registered Advisor. He is NSE’s Certified Investment Analysis Professional and NSE’s Certified Marketing Professional Level – 4, Authorized Person at IIFL Securities, AMFI registered Mutual Funds Distributor having 10+ years of experience in the market. Please consult your Financial Advisor before taking any Investment decisions. This post is an Educational post and Stocksbaazigar is not responsible for your Gains/Losses. Thank You.

Performance of stocks listed in last three years

Performance of IPOS

Primary Market participants take utmost benefits of price discovery mechanism of IPO listings. Most of the times they earn good listing gains. But sometimes things don’t work in their favor. Either Market conditions don’t support or valuations seems too high. IPOs listed in discount, keep breaking down further. Hence Investors take losses and exit rather than holding those stocks and facing big losses further. There were also IPO Opportunities in which Primary Market investors have made 50-80% listing gains. Exiting the Stocks listed on Discount during IPO listing is easier decision than to decide EXIT strategy of Stocks which list at high premium and still see further buying interest. Booking partial profits and holding rest of the stocks with Stop loss is common practice to deal such situation. If your pocket permits you can hold those stocks for long term. Very few people manage to do it. As per human psychology Riding Profits is more difficult decision that sitting on losses for long times. This is due to fear of losing Listing Gains which are visible in front of you. Only deep pockets allow some investors to overcome this fear. When we see Technical Analysis Expert Prakash Gaba Sir holding HDFC bank stocks from IPO times, we feel, “Oh ! I wish I could do that too”. It is easy to say but hard to do. Can we hold stocks listed in IPO for atleast 3 years? OK, Let’s check out how IPOs in the last three years performed to understand this. I have uploaded IPOs which are listed in Calendar years 2019,2020, 2021 and recent listings upto 25th Sept 2022. Total 118 stocks listed in the above mentioned period and their absolute returns is shown in the tables. Please note, I am discussing only those IPOs in details which have doubled the wealth of Investors. First let us see how IPOs listed from 2019 performed. You can see 85 stocks are still trading in profits since their listing prices; 32 Stocks out of these 118 stocks have doubled the wealth of Investors. 33 stocks out of 118 are trading in Negative which amounts to 27% of the total IPOs listed. But Prices of 8 out of them have more than halved which can be termed as very heavy losses. PayTm (-68%), Survoday Small Finance Bank (-67%), Cartrade Tech (-60%), Fino Payments Bank (-58%), Sterling and Wilson Solar (-57%), AGS Transacts technologies (-52%), Windlas Biotech Ltd (-50%) and PB Fintech Ltd (-50%) are the stocks which are down by more than 50% since their listings. As I mentioned in the start of this paragraph, we will discuss stocks that gave more than 100% returns in details now. For easier analysis, I have shared more details about them in the separate post here. Disclaimer: Stocksbaazigar Mr. Deepak Doddamani is not a SEBI registered Research Analyst. He is NSE’s Certified Investment Analysis Professional, NSE’s Certified Marketing Professional Level-4, AMFI registered Mutual Funds Distributor, Authorized Person at IIFL securities ltd, MBA and B.Tech. This post is for educational purpose. Please consult your financial advisor before taking any investment or trading decision. Thank you.

Tata Steel Mega Merger explained

Tata Steel Mega Merger

As per the filing of exchange on 23rd Sept 2022, Tata Steel will merge seven of its subsidiaries in itself. This decision was long awaited. There were plans of amalgamation of Tata Metaliks into Tata Steel Long Products. Now that plan is shelved completely. As per new plan four listed companies Tata Steel Long Products (TSPL), Tinplate Company of India Ltd (TCIL), Tata Metaliks Ltd (TML), TRF Ltd and three unlisted companies Indian Steel and Wire Products Ltd (ISWL), Tata Steel Mining Ltd (TSML), S & T Mining Company will be merged into Tata Steel Ltd. This amalgamation is subject to approval of majority share holders, exchanges, SEBI and other related authorities. The Board has approved SWAP ratio of these as follows: For every 10 shares of Tata Metaliks 79 shares of Tata Steel For every 10 shares of Tata Steel Long Products 67 shares of Tata Steel For every 10 shares of The Tinplate Company of India 33 shares of Tata Steel For every 10 shares of TRF 17 shares of Tata Steel Enlisting the benefits that will be achieved by this Mega Merger of Tata Steel All the Metals and Mining companies will come under One-roof simplifying the group structure. Synergies in Procurement, Operations, technologies and finances will help in long term future. The cost of Royalty to be paid to Govt will reduce significantly. Raw material costs, overhead costs, administration costs, logistic costs will be reduced. Focused leadership and strategy team can define better future for Tata Steel Optimal use of facilities, resources, funds and human resources can be planned More value creation for shareholder’s possible by merged entity Which shares to get benefited by this Mega Merger? In the long term parent company Tata Steel will get benefited. For the same reason shares of Tata Steel traded 4.1% high in the morning before profit booking took place as Market starts falling rapidly. Even though all the listed subsidiaries were down on Friday session after the News came out Analysts came to conclusion that this Merger will help Tata Steel Long Products and Tata Metaliks more than Tata Steel. On TRF and Tinplate the views are neutral. Corporate Action news always brings spikes in the stocks involved. But then they generally see profit booking and stocks corrects more than its actual price from where it started. This happens because many big people who have inside news already take positions in such stocks and sell those stocks once news goes public. Business channels call it ‘Buy on rumors and Sell on News’. Therefore it is my humble request to all that if you are planning to trade these stocks on Monday be careful about your quantities and stop losses. These corporate developments take 8-12 months to actual realize on ground levels. So it is always better to wait. You can buy these stocks before Record date and get benefited rather than getting stuck on wrong side in the euphoria. Disclaimer: Stocksbaazigar Mr. Deepak Doddamani is not a SEBI registered investment analyst. He is NSE’s Certified Investment Analysis Professional (NCIAP), NSE’s Certified Marketing Professional Level – 4, AMFI registered Mutual Funds Distributor, Authorized Person at IIFL Securities and MBA, B.Tech. This post is for the educational purpose. Please consult your financial advisor before taking any investment/trading decision. Thank You.

Diwali 2022 picks by Stocksbaazigar

Diwali 2022

Today on the 22nd Sept 2022 Indian stock markets reacted to the 75 bps rate hike by Fed. The hawkish commentary of Jerome Powell and his determination to arrest inflation on any cost (by rising rates till 4.6% till 2023 end) has not been taken positively by the markets. US Markets and other foreign markets were down and SGX Nifty gave negative cues in the morning. It was clear that Nifty and Bank Nifty both will open negative but it was interesting to see whether buying will happen or not at the dips? Indian Markets have shown great resilience thanks to Liquidity by FIIs and DIIs. China Plus One helped Indian Markets in last two years. Europe Plus One is helping in this year. Europe is facing high inflation and energy crisis. America is facing Slowdown and some countries are standing on the edge of Recession. Fortunately Indian Markets seems little decoupled by whatever is happening globally. Whether it is inherent strength of Indian Markets or just a bubble waiting to get burst only time will tell. Currently Rupee has depreciated to record levels, inflation is concern, and Stocks are trading at inflated valuations. None of these are affecting sentiments of Indian investors. 16500 has become very strong support level on Nifty. So even if Markets fall from here, we might see good buying opportunity only. Samvat 2079 showed some really interesting stories in India. Stocks which outperformed in the year 2020-21 saw huge profit booking. Tata 1Mg’s disruption and increasing competition in pathology sectors saw heavy decline in stocks like Metropolis, Dr Lal Pathlabs and Thyrocare in this year. Hospital stocks too corrected heavily as Covid-waves were really mind than earlier waves. IT stocks which gained good traction during Work From Home culture of Covid-Times saw 20-30% corrections from their highs. Steel, Aluminum and Mining sector stocks which were roaring high due to increased prices corrected too. Surprisingly rate sensitive stocks like NBFCs and Banks kept Nifty and Bank Nifty managed to higher levels. Auto Numbers were better than last year and Stocks like M & M, Escorts were real winners. Adani Group stocks gave multi-bagger returns to their investors and made Adani second richest person in the world briefly on 17th Sept 2022. Analysts who used to say “Never go short on India” started saying “Adani ko short nahi karneka”. Credit Insights warning about Adani Group’s companies being ‘Deeply overleveraged’ was completely neglected by the Indian Retail Investors. Gautam Adani decided to cancel his plans to de-list Adani Power seeing how much trust retail Investors have in his stocks. In the year 2022, Boycott Bollywood and Cancel culture affected Entertainment and Films Distributions stocks adversely. Aviation stocks saw huge correction due to high Fuel prices and frequent incidents which affected safety of the passengers. Hotel and Amusement Park stocks saw good rise thanks to increasing footfalls. They even raised their Prices which increased their margins. Due to high inflation, investors are hiding in FMCG stocks like ITC, HUL etc. ITC moved faster than Rajdhani Express this year shutting mouth of all the Meme-Makers. Now as the September months is about to end and Navratri and Dusshera is around the corner, we must focus on Festival stocks which can give good returns till Diwali 2022. Diwali is starting from 19th November this year. Stocksbaazigar believes that Defense Sector stocks, Adani Group stocks and Auto Sector stocks which are now highly overvalued might see some profit booking and other sectors which are directly or indirectly linked to Festival season will do good. Sugar sector stocks, Paper Stocks, have given good returns till date due to their high demand and low supply. So I am not mentioning them separately. But yes, Diwali is all about Sweets and Balrampur Chini stock should make your portfolio sweeter. Titan and Kalyan Jewellers might also do good. Tanishq is much aspired and trusted brand in this segment. Hence Titan will be my first choice. Stocks related to Shoes (Bata, Metro, Relaxo) and Clothes (ABFRL, Nykaa, Arvind, Raymonds) etc. can be kept on radar. People do buy lot of things on EMI during Flipkart Big Billion and Amazon Great Indian Festivals. Credit Card companies stocks, Bajaj Finserve and Bajaj Finance stocks etc. can be bought to play this story. Home Appliances made major buying Items during Diwali after Electronics and Clothing. So stocks like Dixon tech, Voltas etc. can be included for two months. In the Beverages, United Spirits can be accumulated. Remember you can hold it till New Year too. Other stocks like Logistics companies which have been corrected can make to your short term portfolio. All Cargo, Snowman logistics seems highly corrected. Diwali can never be completed without lights. Havells, Surya Roshni etc. neglected stocks might surprise you in the coming days. Many people prefer that their new vehicles should reach their homes on Dusshera. But booking of those happens almost 4-6 months ahead. So I don’t think Four-Wheeler can make to my list of Diwali stocks. But I can definity include Bajaj Auto, Hero MotoCorp and TVS in this list. In short, this year Diwali will be much bigger as India has came out of Covid completely. We saw how Ganesh Utsav was celebrated. I am expecting same enthusiasm and same joys in Diwali 2022. People may not be spending much in regular days, but they are spending good on Festivals in 2022 year. So let’s be bullish on Market irrespective of Global cues. We can make good Money till Diwali if we select right stocks and allocate right funds for them. This is just a guiding post. You must do your own research or take advice from your Financial Advisor. Disclaimer: Stocksbaazigar Mr.Deepak Doddamani is not a SEBI registered research analyst. He is NSE’s Certified Investment Analysis Professional, NSE’s Marketing Professional level – 4, AMFI registered Mutual Fund distributor, Authorized Person of IIFL Securities and MBA, B.Tech. He is active in market since 2009.

Why AstraZeneca India share price is falling?

Oxford-AstraZeneca is a Good Vaccine with really bad Communication AstraZeneca Pharma India Ltd (AZPIL) is a listed Indian subsidiary of AstraZeneca Plc. UK. It is headquartered in Bengaluru Karnataka since 1979 and employees more than 1400 people in India. AstraZeneca India is in the business of manufacturing and marketing of Pharmaceutical products in healthcare sector. Company manufactures wide variety of products in segments like Gastrointestinal, Respiratory, Cardiovascular, Neuroscience, Cancer and infection etc. diseases. AstraZeneca replaced Merck & Co. to become manufacturer of Vaccine targeting Sars-Cov-2 produced by Oxford University’s Jenner Institute and Vaccitech in the March 2020. The Oxford-AstraZeneca Vaccine program was financed by Oxford Science Innovation, Google Ventures, Sequoia Capitals and other such sponsors. On 30th Dec 2020 the vaccine was approved first by UK for their vaccination program against Covid pandemic. Since then several countries in the world approved Oxford-AstraZeneca vaccine for their Vaccination programs against Coronavirus spread. In India it is Marketed as Covishield. AstraZeneca India Share Price In the March 2020 when Global Markets saw bloodbath due to panic and uncertainty about n-Coronavirus pandemic. AstraZeneca India share made it’s 52 week low of 2015.40. In those days there was no vaccine available for Coronavirus and experts said it will take at least 2 to 5 years to develop an effective vaccine for the Covid-19. Stocks like Cipla, Glenmark Pharma which were manufacturer of medicines required for treating the symptoms of Covid showed good rally. Hospital and Pathology stocks saw good buying as the number of active cases of pandemic started to increase. First Pfizer and then AstraZeneca stocks started climbing up as they declared that they will work for developing Vaccines on Covid-19. Fortunately in March 2021, world has many Vaccines against Coronavirus and they are being upgraded to fight the new variants too. In India we majority of population is taking vaccine developed by Serum Institute Pune while most effective vaccine still seems to be the one which every Politician and Rich man is taking – developed by Bharat Biotech. While in Western world AstraZeneca and Pfizer are being used by large number of countries. This helped AstraZeneca India share price too. It made 52 W high of 4970 before Controversy started pulling it down again. On 26th March 2021, share price closed at 3084. Lets discuss why AstraZeneca India Share price is falling so rapidly? Oxford-AstraZeneca Vaccine Concerns Oxford-AstraZeneca Covid Vaccine was welcomed positively by many Scientists and Countries. They believed in its potential to protect huge population of the world from the Coronavirus Pandemic. Everything was going well until some countries from Europe decided to suspend their Vaccine Program or completely ban this vaccine due to side effect like Blood-Clotting. Millions of people have been vaccinated so far and number of people who got any side effects like Nausea, Fever, Pain are very small. But blood-clotting was much severe side effect than these hence confidence in the Vaccine started shaking. It automatically increased their confidence in Pfizer and BioNtech vaccine. The Netherland, Denmark, Ireland, Iceland and Norway were some of the countries who first suspended use of AstraZeneca Vaccine due to blood-clot issue. In 15 cases blood clot in veins and in 22 cases blood clot formation in lungs were found in European Union and Britain said the administrators who administered the Vaccine Program. Following which the rollercoaster of AstraZeneca share price started which affected AZPIL share in India too. To answer this questions AstraZeneca came up with press-conference and claimed that their own data showed that there is no such side-effect of their Covid-19 Vaccine and it is completely safe with 79% efficacy. Here they goofed up again as US National Institutes of Allergy and Infectious Diseases (NIAID) said that company is lying and current data shows that efficacy is between 69-74%. It also criticized AstraZeneca for providing outdated information. Many experts see it as a desperation of AstraZeneca to stay in competition with Pfizer by showing higher efficacy.